Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Barone

Showing results (331-340 of 399) with videos related to

Pageof 40
Sort By:
Scientific Reports|May 30, 2015
Nonequilibrium fluctuations as a distinctive feature of weak localizationC Barone, F Romeo, S Pagano, et al.
Journal of Cardiovascular Pharmacology|October 6, 2001
Enrasentan improves survival, limits left ventricular remodeling, and preserves myocardial performance in hypertensive cardiac hypertrophy and dysfunctionR N Willette, K M Anderson, A H Nelson, et al.
Archives of Virology. Supplementum|January 1, 1996
Rotavirus subunit vaccinesM E Conner, S E Crawford, C Barone, et al.
British Journal of Cancer|November 24, 2012
KRAS mutational status affects oxaliplatin-based chemotherapy independently from basal mRNA ERCC-1 expression in metastatic colorectal cancer patientsM Basso, A Strippoli, A Orlandi, et al.
Psychoneuroendocrinology|September 3, 2025
How to study the menstrual cycle as a continuous variable: Implementing phase-aligned cycle time scaling (PACTS) with the menstrualcycleR packageAnisha Nagpal, Katja M Schmalenberger, Jordan C Barone, et al.
Cellular and Molecular Biology (Noisy-Le-Grand, France)|June 13, 2015
Letter to Editor: Cytochrome b gene expression in down syndrome subjectsM Salemi, C Barone, C Romano, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 23, 1998
A phase II study of irinotecan alternated with five days bolus of 5-fluorouracil and leucovorin in first-line chemotherapy of metastatic colorectal cancerE Van Cutsem, C Pozzo, H Starkhammar, et al.
Plos One|September 8, 2017
The prolyl 4-hydroxylase inhibitor GSK360A decreases post-stroke brain injury and sensory, motor, and cognitive behavioral deficitsJin Zhou, Jie Li, Daniel M Rosenbaum, et al.
Brain Research. Molecular Brain Research|September 5, 2001
Characterisation of gene expression changes following permanent MCAO in the rat using subtractive hybridisationS Bates, S J Read, D C Harrison, et al.
Journal of Clinical Medicine|February 27, 2026
RNA-Based Biomarkers for Diagnostic Discrimination of Ischemic and Hemorrhagic Stroke: A Systematic ReviewJan Emmerich, Aditya Chanpura, Frank C Barone, et al.
Pageof 40

Showing results (331-340 of 399) with videos related to

Sort By:
Pageof 40
Scientific Reports|May 30, 2015
Nonequilibrium fluctuations as a distinctive feature of weak localizationC Barone, F Romeo, S Pagano, et al.
Journal of Cardiovascular Pharmacology|October 6, 2001
Enrasentan improves survival, limits left ventricular remodeling, and preserves myocardial performance in hypertensive cardiac hypertrophy and dysfunctionR N Willette, K M Anderson, A H Nelson, et al.
Archives of Virology. Supplementum|January 1, 1996
Rotavirus subunit vaccinesM E Conner, S E Crawford, C Barone, et al.
British Journal of Cancer|November 24, 2012
KRAS mutational status affects oxaliplatin-based chemotherapy independently from basal mRNA ERCC-1 expression in metastatic colorectal cancer patientsM Basso, A Strippoli, A Orlandi, et al.
Psychoneuroendocrinology|September 3, 2025
How to study the menstrual cycle as a continuous variable: Implementing phase-aligned cycle time scaling (PACTS) with the menstrualcycleR packageAnisha Nagpal, Katja M Schmalenberger, Jordan C Barone, et al.
Cellular and Molecular Biology (Noisy-Le-Grand, France)|June 13, 2015
Letter to Editor: Cytochrome b gene expression in down syndrome subjectsM Salemi, C Barone, C Romano, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 23, 1998
A phase II study of irinotecan alternated with five days bolus of 5-fluorouracil and leucovorin in first-line chemotherapy of metastatic colorectal cancerE Van Cutsem, C Pozzo, H Starkhammar, et al.
Plos One|September 8, 2017
The prolyl 4-hydroxylase inhibitor GSK360A decreases post-stroke brain injury and sensory, motor, and cognitive behavioral deficitsJin Zhou, Jie Li, Daniel M Rosenbaum, et al.
Brain Research. Molecular Brain Research|September 5, 2001
Characterisation of gene expression changes following permanent MCAO in the rat using subtractive hybridisationS Bates, S J Read, D C Harrison, et al.
Journal of Clinical Medicine|February 27, 2026
RNA-Based Biomarkers for Diagnostic Discrimination of Ischemic and Hemorrhagic Stroke: A Systematic ReviewJan Emmerich, Aditya Chanpura, Frank C Barone, et al.
Pageof 40